TrialPath
Recruiting

Understanding the Transition from Normal Melanocytes to Nevus to Melanoma

NCT06605417 · Fundacion Clinic per a la Recerca Biomédica
In plain English

Click the button to translate this study into plain language — what it is, who qualifies, and what participation looks like.

Official title
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma (NevustoMel)
About this study
NevustoMel is an international multicentric retrospective cohort study with molecular and experimental design. It will involve the genomic characterization of cell-free DNA and affected tissues from patients. Methylomics and single-cell multi-omics will be used to identify co-existing molecular (transcriptional and epigenomic) states at single-cell level and will be generated from affected tissues. These results will be exploited using machine learning-assisted integration of multi-modal transcriptomics, epigenomics and spatial information. Integrated analyses of single-nucleus RNA sequencing from a selection of frozen tissues and spatial transcriptomics on formalin-fixed paraffin-embedded samples will allow the comparison of the findings to ground-state Human Developmental Cell Atlas data. Distinctions will be validated either with in situ hybridization (such as RNA sequencing) or immunostaining on test cohort tissues. These results will be complemented with in vitro functional analyses, high throughput sequencing and bioinformatic analyses.
Eligibility criteria
Inclusion criteria: * Congenital nevus with estimated size of 20 cm * Be over 18 years of age Exclusion criteria: * No available biological material * Not having signed the informed consent
Study design
Enrollment target: 100 participants
Age groups: child, adult, older_adult
Timeline
Starts: 2024-01-01
Estimated completion: 2026-11-30
Last updated: 2025-02-27
Interventions
Genetic: MethylomicsGenetic: RNA sequencingGenetic: Spatial transcriptomicsGenetic: Liquid biopsy
Primary outcomes
  • Molecular identity profiles (26 months)
Sponsor
Fundacion Clinic per a la Recerca Biomédica · other
With: Institut National de la Santé Et de la Recherche Médicale, France, University Hospital Tuebingen, University of Florence, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, University Of Perugia, German Cancer Research Center, Karolinska Institutet, Maria Sklodowska-Curie National Research Institute of Oncology, Institut Curie, Medical University of Gdansk, Princess Maxima Center for Pediatric Oncology, Institut Català d'Oncologia
Contacts & investigators
ContactSusana Puig Sardà, MD, PhD · contact · spuig@clinic.cat · +34932275400
ContactAdrián López Canosa, PhD · contact · lopez64@recerca.clinic.cat
All locations (2)
French National Institute of Health and Medical ResearchRecruiting
Marseille, France
Hospital Clínic de Barcelona (Dermatology service)Recruiting
Barcelona, Spain
Understanding the Transition from Normal Melanocytes to Nevus to Melanoma · TrialPath